Dysfunction of glutathione s-transferase leads to excess 4-hydroxy-2-nonenal and h2o2 and impaired cytokine pattern in cultured keratinocytes and blood of vitiligo patients

Antioxidants and Redox Signaling

Volumn 13, Issue 5, 2010, Pages 607-620

  Kostyuk, Vladimir A ^a,b   Potapovich, Alla I ^a,b   Cesareo, Eleonora ^a   Brescia, Serena ^a   Guerra, Liliana ^a   Valacchi, Giuseppe ^c,d   Pecorelli, Alessandra ^c   Deeva, Irina B ^a,e   Raskovic, Desanka ^a   De Luca, Chiara ^a   Pastore, Saveria ^a   Korkina, Liudmila G ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b BELARUSIAN STATE UNIVERSITY   (Belarus)

^c UNIVERSITY OF SIENA   (Italy)

^d Kyung Hee University   (South Korea)

^e FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; CATALASE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUTATHIONE TRANSFERASE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROGEN PEROXIDE; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN KINASE B; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; KERATINOCYTE; MALE; MELANOCYTE; MELANOGENESIS; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHOOL CHILD; SIGNAL TRANSDUCTION; VITILIGO;

ADOLESCENT; ADULT; AGED; ALDEHYDES; CATALASE; CHILD; COCULTURE TECHNIQUES; CYTOKINES; ERYTHROCYTES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE TRANSFERASE; HUMANS; HYDROGEN PEROXIDE; INTERLEUKIN-6; KERATINOCYTES; MALE; MELANOCYTES; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE II; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SOXB1 TRANSCRIPTION FACTORS; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS; VITILIGO; YOUNG ADULT;

EID: 77953494073     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.2976     Document Type: Article

References (49)

1. Aebi H. Catalase in vitro. Methods Enzymol 105: 121-126, 1984.
2. Alin P, Danielson UH, and Mannervik B. 4-hydroxyalk-2-enals are substrates for glutathione transferase. FEBS Lett 179: 267-279, 1985.
3. Bartosz G. Reactive oxygen species: Destroyers or messengers? Biochem Pharmacol 77: 1303-1315, 2009.
4. Bolt HM and Their R. Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr Drug Metab 7: 613-628, 2006.
5. Bondanza S, Maurelli R, Paterna P, Migliore E, Di Giacomo F, Primavera G, Paionni E, Dellambra E, and Guerra L. Keratinocyte cultures from involved skin in vitiligo patients show an impaired in vitro behaviour. Pigment Cell Res 20: 288-300, 2007.
6. Brown GE, Silver GM, Reiff J, Allen RC, and Fink MP. Polymorphonuclear neutrophil chemiluminescence in whole blood from blunt trauma patients with multiple injuries. J Trauma 46: 297-305, 1999.
7. Casp, CB, She JX, and McCormack, WT. Genetic association of the catalase gene (CAT) with vitiligo susceptibility. Pigment Cell Res 15: 62-66, 2002.
8. Cesareo E, Parker LJ, Pedersen JZ, Nuccetelli M, Mazzetti AP, Pastore A, Federici G, Caccuri AM, Ricci G, Adams JJ, Parker MW, and Lo Bello M. Nitrosylation of human glutathione transferase P1-1 with dinitrosyl diglutathionyl iron complex in vitro and in vivo. J Biol Chem 280: 42172-42180, 2005.
9. Chen J, Kinter M, Shank S, Cotton C, Kelley TJ, and Ziady AG. Dysfunction of Nrf-2 in CF epithelia leads to excess intracellular H2O2 and inflammatory cytokine production. PLoS One 3: e3367, 2008.
10. Cho SG, Lee YH, Park HS, Ryoo K, Kang KW, Park J, Eom SJ, Kim MJ, Chang TS, Choi SY, Shim J, Kim Y, Dong MS, Lee MJ, Kim SG, Ichijo H, and Choi EJ. Glutathione Stransferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J Biol Chem 276: 12749-12755, 2001.
11. Lee MJ, Kim SG, Ichijo H, and Choi EJ. Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J Biol Chem 276: 12749-12755, 2001.
12. Codreanu SG, Zhang B, Sobecki SM, Billheimer DD, and Liebler DC. Global analysis of protein damage by the lipid electrophile 4-hydroxy-2-nonenal. Mol Cell Proteomics 8: 670-680, 2009.
13. Dammak I, Boudaya S, Ben Abdullah F, Turki H, Attia H, and Hentati B. Antioxidant enzymes and lipid peroxidation at the tissue level in patients with stable and active vitiligo. Int J Dermatol 48: 476-480, 2009.
14. Dell'Anna ML, Urbanelli S, Mastrofrancesco A, Camera E, Iacovelli P, Leone G, Manini P, D'Ischia M, and Picardo M. Alterations of mitochondria in peripheral blood mononuclear cells of vitiligo patients. Pigment Cell Res 16: 553-559, 2003.
15. D'souza A, Kurien, BT, Rodgers R, Shenoi J, Kurono S, Matsumoto H, Hensley K, Nath SK, and Scofield RH. Detection of catalase as a major protein target of the lipid peroxidation product 4-HNE and the lack of its genetic association as a risk factor in SLE. BMC Med Gen 9: 62, 2008.
16. 2 scavenging and signalling. Antioxid Redox Signal 10: 1565-1575, 2008.
17. Guerra L, Primavera G, Raskovic D, Pellegrini G, Golisano O, Bondanza S, Paterna P, Sonego G, Gobello T, Atzori F, Piazza P, Luci A, and De Luca M. Erbium:YAG laser and cultured epidermis in the surgical therapy of stable vitiligo. Arch Dermatol 139: 1303-1310, 2003.
18. Habig WH, Pabst MJ, and Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130-11739, 1974.
19. Hayes JD, Flanagan JU, and Jowsey IR. Glutathione trans-ferases. Ann Rev Pharmacol Toxicol 45: 51-88, 2005.
20. Hiratsuka A, Saito H, Hirose K, and Watabe T. Marked expression of glutathione S-transferase A4-4 detoxifying 4-hydroxy-2(E)-nonenal in the skin of rats irradiated by ultraviolet B-band light (UVB). Biochem Biophys Res Commun 260: 740-746, 1999.
21. Imokawa G. Autocrine and paracrine regulation of mela-nocytes in human skin and in pigmentary disorders. Pigment Cell Res 17: 96-110, 2004.
22. 10, vitamin E, and selenium supplementation to psoriasis patients. Nutrition 25: 295-302, 2009.
23. Korkina L and Pastore S. The role of redox regulation in the normal physiology and inflammatory diseases of the skin. Front Biosci 1: 123-141, 2009.
24. Kurien BT, Hensley K, Bachmann M, and Scofield RH. Oxidatively modified autoantigens in autoimmune diseases. Free Rad Biol Med 15: 549-556, 2006.
25. Lee AY, Kim NH, Choi WI, and Youm YH. Less keratino-cyte-derived factors related to more keratinocyte apoptosis in depigmented than in normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo. J Invest Dermatol 124: 976-983, 2005.
26. Liu W, Akhand AA, Kato M, Yokoyama I, Miyata T, Kur-okawa K, Uchida K, and Nakashima I. 4-hydroxynonenal triggers an epidermal growth factor-linked signal pathway for growth inhibition. J Cell Sci 112: 2409-2417, 1999.
27. Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani L, Fabiani M, and Fabbri P. New insights into the pathogenesis of vitiligo: Imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 15: 87-92, 2002.
28. Oliveira-Marques de V, Cyrne L, Marinho HS, and Antunes F. A quantitative study of NF-kappaB activation by H2O2: relevance in inflammation and synergy with TNF-alpha. J Immunol 178: 3893-3902, 2007.
29. Paglia DE and Valentine WN. Studies on quantitative and qualitative characterization of erythrocyte glutathione per-oxidase. J Lab Clin Med 70: 158-169, 1967.
30. Park HH, Ha E, Uhm YK, Jin SY, Kim YJ, Chung JH, and Lee MH. Association study between catalase gene polymorphisms and the susceptibility to vitiligo in Korean population. Exp Dermatol 15: 377-380, 2006.
31. Pastore S, Mascia F, Mariotti F, Dattilo C, Mariani V, and Girolomoni G. ERK1=2 regulates epidermal chemokine expression and skin inflammation. J Immunol 174: 5047-5056, 2005.
32. Pizzimenti S, Ferracin M, Sabbioni S, Toaldo C, Pettazzoni P, Dianzani MU, Negrini M, and Barrera G. MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation. Free Rad Biol Med 46: 282-288, 2009.
33. Reed DJ, Babson JR, Beatty PW, Brodie AE, Ellis WW, and Potter DW. High performance liquid chromatography analysis of nanomole levels of glutathione disulphide and related thiols and disulphides. Anal Biochem 106: 55-62, 1980.
34. Roy S, Khanna S, Nallu K, Hunt TK, and Sen CK. Dermal wound healing is subject to redox control. Mol Ther 13: 211-220, 2006.
35. Sampey BP, Carbone DL, Doorn JA, Drechsel DA, and Pe-tersen DR. 4-hydroxy-2-nonenal adduction of extracellular signal-regulated kinase (Erk) and the inhibition of hepato-cyte Erk-Est-like protein-1-activating protein-1 signal trans-duction. Mol Pharm 71: 871-883, 2007.
36. Schallreuter KU, Wood JM, and Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 97: 1081-1085, 1991.
37. Schallreuter KU, Bahadoran P, Picardo M, Slominski A, Elassiuty YE, Kemp EH, Giachino C, Liu JB, Luiten RM, Lambe T, Le Poole IC, Dammak I, Onay H, Zmijewski MA, Dell'Anna ML, Zeegers MP, Cornall RJ, Paus R, Ortonne JP, and Westerhof W. Vitiligo pathogenesis: Autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, orwhat else? Exp Dermatol 17: 139-160, 2008.
38. Sen CK, Khanna S, Babior BM, Hunt TK, Ellison EC, and Roy S. Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing. J Biol Chem 277: 33284-33290, 2002.
39. Snyder LM, Sauberman N, Condara H, Dolan J, Jacobs J, Szymanski I, and Fortier NL. Red cell membrane response to hydrogen peroxide-sensitivity in hereditary xerocytosis and in other abnormal red cells. Br J Haematol 48: 435-444, 1981.
40. Sriwiriyanont P, Ohuchi A, Hachiya A, Visscher MO, and Boissy RE. Interaction between stem cell factor and endothelin-1: Effects on melanogenesis in human skin xenografts. Lab Invest 86: 1115-1125, 2006.
41. Townsend DM, Findlay VL, and Tew KD. Glutathione S-transferases as regulators of kinase pathways and anticancer drug targets. Methods Enzymol 401: 287-307, 2005.
42. Uchida K, Shiraishi M, Naito Y, Torii Y, Nakamura Y, and Osawa TA. Activation of stress signaling pathways by the end product of lipid peroxidation. J Biol Chem 274: 2234-2242, 1999.
43. Uhm YK, Yoon SH, Kang IJ, Chung JH, Yim SV, and Lee MH. Association of glutathione S-transferase gene polymorphisms (GSTM1 and GSTT1) of vitiligo in Korean population. Life Sci 81: 223-227, 2007.
44. Westerhof W and D'Ischia M. Vitiligo puzzle: The pieces fall in place. Pigment Cell Res 20: 345-359, 2007.
45. Wood JM, Gibbons NC, Chavan B, and Schallreuter KU. Computer simulation of heterogeneous single nucleotide polymorphisms in the catalase gene indicates structural changes in the enzyme active site, NADPH-binding and tetramerization domains: A genetic predisposition for an altered catalase in patients with vitiligo? Exp Dermatol 17: 366-371, 2008.
46. Yang Y, Yang Y, Xu Y, Lick SD, Awashti YC, and Boor PJ. Endothelial glutathione-S-transferase A4-4 protects against oxidative stress and modulates iNOS expression through NF-kappa B translocation. Toxicol Appl Pharmacol 230: 187-196, 2008.
47. Yildirim M, Baysal V, Inaloz HS, Kesici D, and Delibas N. The role of oxidants and antioxidants in generalized vitiligo. J Dermatol 30: 104-108, 2003. (Pubitemid 36368109)
48. Zamocky M, Furtmuller PG, and Obinger C. Evolution of catalases from bacteria to humans. Antioxid Redox Signal 10: 1527-1547, 2008.
49. Zhang H and Forman HJ. Signaling pathways involved in phase II gene induction by alpha, beta-unsaturated aldehydes. Toxicol Ind Health 25: 269-278, 2009.